A-B. IMR90 (A) and 293T (B) cells were treated with 25 µM etoposide for 1.5 hours before 20 µg/ml cycloheximide was added. At the indicated time points, whole cell lysates were prepared and immunoblots were probed with the indicated antibodies. C. HeLa cells were transfected with the C464A mutant HA-Mdm2 plasmid. Twenty hours posttransfection, cells were split into 60 mm dishes, and after another 20 hours, treated with the indicated DNA damaging drugs for 3 hours. Afterwards, whole-cell lysates were prepared and immunoblots were probed with the indicated antibodies. D-E. HeLa cells (D) and 293T cells (E) were transfected with the C464A mutant HA-Mdm2 plasmid.
